Cigarette Smoking-Related Carcinoma
Conditions
Brief summary
This clinical trial evaluates the effectiveness of active episodic future thinking (EFT) stimuli for reducing cigarette consumption in cigarette smokers. EFT is an innovative framing method shown to significantly activate brain regions involved in future thinking, planning, and other executive functions. Active EFT stimuli are positive events, unrelated to smoking, that participants anticipate, look forward to, and can vividly imagine happening up to 1 year in the future. Control EFT stimuli are positive past events, unrelated to smoking, that participants can vividly remember happening in the recent past. Active EFT stimuli may help reduce cigarette consumption among cigarette smokers by exposing them to personally relevant future oriented stimuli.
Detailed description
PRIMARY OBJEECTIVE: I. To evaluate the efficacy of episodic future thinking (EFT) for smoking cessation. OUTLINE: Participants are randomized to 1 of 2 arms. ARM I (ACTIVE): Participants receive the active EFT stimulus and use the iCOquit Smokerlyzer carbon monoxide monitor on study. ARM II (CONTROL): Participants receive the control EFT stimulus and use the iCOquit Smokerlyzer carbon monoxide monitor on study.
Interventions
BEHAVIORALSmoking Cessation Intervention
Receive active EFT stimulus
BEHAVIORALSmoking Cessation Intervention (control)
Receive control EFT stimulus
OTHERMedical Device Usage and Evaluation
Use iCOquit Smokerlyzer carbon monoxide monitor
Sponsors
Roswell Park Cancer Institute
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Smoke \>= 10 cigarettes daily * \>32 on the Vividness of Visual Imagery Questionnaire (VVIQ) * No regular use of other tobacco products * In possession of a smartphone with text messaging capabilities * Willing to quit smoking in the next 30 days * Low socioeconomic status * Veteran of the US armed services
Exclusion criteria
* Unable or unwilling to provide verbal consent * Unable or unwilling to provide data to the research team * Current use of nicotine replacement therapy, bupropion, or varenicline * Use of drugs of abuse in the past 30 days * Living in the same household as a participant already enrolled in this study * Unable or unwilling to use nicotine patches
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Concentration of carbon monoxide on breath | From baseline up to 30 days | Will be measured by Micro+Basic carbon monoxide monitor |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Reduction in delay discounting rate | Up to 30 days | participants will be guided to imagine the situational and sensory details for each of the stimuli until the vividness scores are ≥ 4 on a scale of 1-5 (1=very low, 5=very high). |
Countries
United States
Contacts
PRINCIPAL_INVESTIGATORChristine Sheffer
Roswell Park
Outcome results
None listed